Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
ASCI Milestone Awards
Video Abstracts
Conversations with Giants in Medicine
Reviews
Reviews
View all reviews ...
Review Series
The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
Neurodegeneration (Mar 2026)
Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
Pancreatic Cancer (Jul 2025)
Complement Biology and Therapeutics (May 2025)
Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
Microbiome in Health and Disease (Feb 2025)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
LOW BASAL METABOLISM FOLLOWING THYROTOXICOSIS:
II. Permanent Type without Myxedema
Willard Owen Thompson, Phebe K. Thompson
Willard Owen Thompson, Phebe K. Thompson
View:
Text
|
PDF
LOW BASAL METABOLISM FOLLOWING THYROTOXICOSIS:
II. Permanent Type without Myxedema
Text
PDF
Abstract
Authors
Willard Owen Thompson, Phebe K. Thompson
×
Other pages:
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
Other pages:
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
